Seeking Alpha

Oncothyreon (ONTY) agrees to pay Array BioPharma (ARRY) $10M as part of a deal to collaborate on...

Oncothyreon (ONTY) agrees to pay Array BioPharma (ARRY) $10M as part of a deal to collaborate on developing the latter's ARRY-380 molecule for treating breast and other cancers. Oncothyreon is raising the $10M by selling 5M shares and warrants for another 5M shares to BVF Partners.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs